Multiple endocrine neoplasia type 2A

• Published in: Medicina (Kaunas, Lithuania) Vol. 42; no. 3; p. 215
• Main Authors: Juodele, Linas, Krasauskas, Virgilijus, Zindzius, Algimantas, Juozaityte, Elona, Pundzius, Juozas
• Format: Journal Article
• Language: Lithuanian
• Published: Switzerland 2006
• Subjects: Adrenal Gland Neoplasms - diagnosis; Adrenal Gland Neoplasms - diagnostic imaging; Adrenal Gland Neoplasms - genetics; Adrenal Gland Neoplasms - surgery; Adrenalectomy; Adult; Aged; Aged, 80 and over; Carcinoma, Medullary - diagnosis; Carcinoma, Medullary - surgery; Combined Modality Therapy; Female; Humans; Lymph Node Excision; Magnetic Resonance Imaging; Middle Aged; Multiple Endocrine Neoplasia Type 2a - diagnosis; Multiple Endocrine Neoplasia Type 2a - genetics; Multiple Endocrine Neoplasia Type 2a - mortality; Multiple Endocrine Neoplasia Type 2a - therapy; Pedigree; Pheochromocytoma - diagnosis; Pheochromocytoma - diagnostic imaging; Pheochromocytoma - genetics; Pheochromocytoma - surgery; Prognosis; Radiography, Abdominal; Thyroid Neoplasms - diagnosis; Thyroid Neoplasms - surgery; Thyroidectomy; Time Factors; Tomography, X-Ray Computed; Ultrasonography
• ISSN: 1648-9144

Multiple endocrine neoplasia (MEN) type 2A, or Sipple syndrome, is a rare autosomal dominantly inherited syndrome, which is characterized as combination of medullary thyroid carcinoma, pheochromocytoma, primary hyperparathyroidism, sometimes with rarer inherited disorders like Hirschsprung disease and cutaneous lichen amyloidosis. Syndrome is caused by germinative mutations in c-ret protooncogene, which are typical for different MEN 2 syndromes. We report a clinical case of MEN 2A. A 43-year-old female patient was operated on for pheochromocytoma 7 years after diagnosis and treatment of spread medullary thyroid carcinoma. This is the most common combination of MEN 2A tumors. Diagnosis was based upon clinical data, tumors combinations and analysis of inherited endocrine pathology in first-line relatives. This syndrome has already been diagnosed in Lithuania, but in the last decade after determining the genetic basis of MEN 2 and applying modern genetic examinations in clinical praxis, the strategy of diagnostics and prophylaxis of this syndrome has changed and survival prognosis for patients with this syndrome has improved. Conception of pathogenesis and clinical features of MEN 2A syndrome, genetic selection of inheritors of this syndrome is one more step in early cancer diagnosis, which allows to use cancer prevention measures in time, to apply effective treatment and improve patients' prognosis. Reporting this clinical case of MEN 2A we aimed to pay attention of general practitioners to this rare, but in Lithuania diagnosed too, syndrome and its clinic, diagnostic, and treatment features.